Cardinal Capital Management Inc (North Carolina)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Cardinal Capital Management Inc (North Carolina)'s PFE Position: Q2 2026 in Review
Cardinal Capital Management Inc (North Carolina) increased its Pfizer (PFE) stake by 0.69% in Q2 2026, buying an estimated $22.3K and bringing the position to 124,537 shares worth $3M. The position accounts for 0.36% of the portfolio, ranked #82.
Cardinal Capital Management Inc (North Carolina) first reported a position in PFE in Q2 2022 and has held it in 15 quarters since. The position peaked at $4.42M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cardinal Capital Management Inc (North Carolina) held 124,537 shares of Pfizer worth $3M as of Q2 2026.
- Cardinal Capital Management Inc (North Carolina) bought 853 Pfizer shares in Q2 2026, an estimated $22.3K.
- Pfizer made up 0.36% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #82 holding.
- Cardinal Capital Management Inc (North Carolina) first reported a position in Pfizer in Q2 2022 and has held it in 15 quarters since.
- Cardinal Capital Management Inc (North Carolina)'s Pfizer position peaked at $4.42M in Q4 2022.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.